Literature DB >> 3474453

Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs.

M C Walker, C N Parris, J R Masters.   

Abstract

The in vitro drug sensitivities of 5 human testicular tumor cell lines (Tera II, SuSa, NEC-8, 833K, T3B1) and 5 human bladder carcinoma cell lines (RT4, RT112, T24, HT1197, HT1376) were compared. Cytotoxicities of cisplatin and doxorubicin were assessed by inhibition of colony-forming ability during continuous exposure to a range of drug concentrations. The ranges of the drug concentrations required to kill 70% of clonogenic cells obtained against the testicular cell lines were 1-7 ng/ml and 21-161 ng/ml for doxorubicin and cisplatin, respectively, compared with 4-19 ng/ml and 112-431 ng/ml for the bladder cell lines. This study shows that continuous cell lines retain the relative clinical chemosensitivities of their tumors of origin. The results also indicate that testicular tumor cells are inherently more sensitive to the cytotoxic effects of chemotherapeutic drugs than are bladder cancer cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3474453

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

1.  Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells.

Authors:  Caryl J Giuliano; Sarah J Freemantle; Michael J Spinella
Journal:  Curr Cancer Ther Rev       Date:  2006-08-01

2.  Development and Validation of Endovascular Chemotherapy Filter Device for Removing High-Dose Doxorubicin: Preclinical Study.

Authors:  Anand S Patel; Maythem Saeed; Erin J Yee; Jeffrey Yang; Gregory J Lam; Aaron D Losey; Prasheel V Lillaney; Bradford Thorne; Albert K Chin; Sheena Malik; Mark W Wilson; Xi C Chen; Nitash P Balsara; Steven W Hetts
Journal:  J Med Device       Date:  2014-08-19       Impact factor: 0.582

Review 3.  New cisplatin analogues in development. A review.

Authors:  Raymond B Weiss; Michaele C Christian
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

4.  Intravesical chemotherapy: combination with dimethyl sulfoxide does not enhance cytotoxicity in vitro.

Authors:  L Walker; M C Walker; C N Parris; J R Masters
Journal:  Urol Res       Date:  1988

5.  Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway.

Authors:  R Koster; H Timmer-Bosscha; R Bischoff; J A Gietema; S de Jong
Journal:  Cell Death Dis       Date:  2011-04-21       Impact factor: 8.469

6.  Twenty-ninth annual meeting of the British Association for Cancer Research in conjunction with the third annual meeting of the Association of Cancer Physicians. March 21-24, 1988, Norwich, U.K. Abstracts.

Authors: 
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

7.  O6-alkylguanine-DNA-alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines.

Authors:  M C Walker; J R Masters; G P Margison
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

8.  Heat shock protein expression in testis and bladder cancer cell lines exhibiting differential sensitivity to heat.

Authors:  E H Richards; J A Hickman; J R Masters
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

9.  Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.

Authors:  M W Sark; H Timmer-Bosscha; C Meijer; D R Uges; W J Sluiter; W H Peters; N H Mulder; E G de Vries
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

10.  Exceptional sensitivity of testicular germ cell tumour cell lines to the new anti-cancer agent, temozolomide.

Authors:  M F Pera; B Köberle; J R Masters
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.